Evidence map›Paper›PMID 35253761›Full record

ArticleJournal of Alzheimer's disease : JAD2022

Characterizing Network Selectiveness to the Dynamic Spreading of Neuropathological Events in Alzheimer's Disease.

Wenchao Li, Defu Yang, Chenggang Yan, Minghan Chen, Quefeng Li, Wentao Zhu, Guorong Wu, Alzheimer’s Disease Neuroimaging Initiative

Open access · greenAbstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Wenchao LiIntelligent Information Processing Laboratory, Hangzhou Dianzi University, Hangzhou, China.
Defu YangIntelligent Information Processing Laboratory, Hangzhou Dianzi University, Hangzhou, China.
Chenggang YanIntelligent Information Processing Laboratory, Hangzhou Dianzi University, Hangzhou, China.
Minghan ChenDepartment of Computer Science, Wake Forest University, Winston-Salem, NC, USA.
Quefeng LiDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Wentao ZhuResearch Center for Healthcare Data Science, Zhejiang Lab, Hangzhou, Zhejiang, China.
Guorong WuDepartment of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Alzheimer’s Disease Neuroimaging Initiative
Hangzhou Dianzi University · CNUniversity of North Carolina at Chapel Hill · USZhejiang Lab · CNWake Forest University · US

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
Understanding Selectivity Mechanisms of Network Vulnerability and Resilience in Alzheimer's Disease by Establishing a Neurobiological Basis through Network NeuroscienceRF1AG068399 · NIA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WU, GUORONG · 2020 to 2020
$1.9M
Statistical Methods for Integrative Analysis of Large Scale Neuroimaging DataR01AG073259 · NIA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LI, QUEFENG · 2021 to 2025
$1.8M
Uncovering the Heterogeneity of Neurodegeneration Trajectories in Alzheimer's Disease Using a Network Guided Reaction-Diffusion ModelR03AG073927 · NIA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WU, GUORONG · 2021 to 2022
$317k
Continuing Tool Development for Longitudinal Network Analysis: Enriching the Diagnostic Power of Disease-Specific Connectomic Biomarkers by Deep Graph LearningR03AG070701 · NIA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WU, GUORONG · 2021 to 2022
$303k
NIA NIH HHS R01 AG073259NIA NIH HHS R03 AG070701NIA NIH HHS R03 AG073927NIA NIH HHS RF1 AG068399NIA NIH HHS U01 AG024904
6 · The paper itself

Abstract

backgroundMounting evidence shows that the neuropathological burdens manifest preference in affecting brain regions during the dynamic progression of Alzheimer's disease (AD). Since the distinct brain regions are physically wired by white matter fibers, it is reasonable to hypothesize the differential spreading pattern of neuropathological burdens may underlie the wiring topology, which can be characterized using neuroimaging and network science technologies.

objectiveTo study the dynamic spreading patterns of neuropathological events in AD.

methodsWe first examine whether hub nodes with high connectivity in the brain network (assemble of white matter wirings) are susceptible to a higher level of pathological burdens than other regions that are less involved in the process of information exchange in the network. Moreover, we propose a novel linear mixed-effect model to characterize the multi-factorial spreading process of neuropathological burdens from hub nodes to non-hub nodes, where age, sex, and APOE4 indicators are considered as confounders. We apply our statistical model to the longitudinal neuroimaging data of amyloid-PET and tau-PET, respectively.

resultsOur meta-data analysis results show that 1) AD differentially affects hub nodes with a significantly higher level of pathology, and 2) the longitudinal increase of neuropathological burdens on non-hub nodes is strongly correlated with the connectome distance to hub nodes rather than the spatial proximity.

conclusionThe spreading pathway of AD neuropathological burdens might start from hub regions and propagate through the white matter fibers in a prion-like manner.

Indexed as

Alzheimer DiseaseConnectomeBrainHumansNeuroimagingNeuropathologyAlzheimer’s diseasebrain networkshub nodelinear mixed-effect modellongitudinal neuroimages

Identifiers

PMID35253761
PMCPMC9482760
OpenAlexW4214666516

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.